SHEILA MADGEDI: Open Payments
NPI 1487262275 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 44 payments from 9 companies in 2025. Trend: 2023 $327 · 2024 $724 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $582 |
| GlaxoSmithKline, LLC. | 10 | $208 |
| Lilly USA, LLC | 5 | $110 |
| Corcept Therapeutics | 2 | $47 |
| Exact Sciences Corporation | 2 | $47 |
| Astellas Pharma US Inc | 1 | $32 |
| ABBVIE INC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| Amgen Inc. | 1 | $18 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, BREZTRI, Korlym, Cologuard Collection Kit, Veozah.
Industry payments across CA — which companies pay providers there.
